Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Experimental System Myovoice

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT04762043Not ApplicableCompletedPrimary

MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments

Showing all 1 trials

Research Network

Common Treatments

  • Experimental System Myovoice1
  • Reference System Electrolarynx1

Active Sponsors

  • Altec Inc.1

Top Investigators

Related Conditions

  • Speech Alaryngeal1
  • Communication Aids For Disabled1
  • Speech Disorders1
  • Speech Intelligibility1
  • Speech Perception1

Activity Timeline